ML Randi, E Ruzzon, G Luzzatto, F Tezza, A Girolami, and F Fabris. 2005. “Safety Profile of Hydroxyurea in the Treatment of Patients With Philadelphia-Negative Chronic Myeloproliferative Disorders”. Haematologica 90 (2). Pavia, Italy, 261-62. https://doi.org/10.3324/%x.